Published Medical Literature

Multiple Aggregated, Yellow-White Globules: Indicator of Basal Cell Carcinoma?

Non-Melanoma Skin Cancer and COVID-19: Modifications to Current Radiotherapy

Genetic Features of Virus-Positive Versus Virus-Negative Merkel Cell Carcinoma

Genetic Link Between Inflammatory Bowel Disease and Skin Cancer?

International Researchers Reveal Clues to Aggressive Skin Cancers

Finnish Researchers Find Unexpected Features of Recurrent and Metastatic Skin Cancers

Mohs Micrographic Surgery for Facial Skin Cancers: Do Patients Have Realistic Expectations?

Nivolumab Prior to Surgery in Patients With Merkel Cell Carcinoma

Could Non-Melanoma Skin Cancer Be Linked to Exfoliation Glaucoma?

Is Parkinson’s Disease Associated With Development of Skin Cancer?

miR-375 in Merkel Cell Carcinoma: An Intracellular Oncogene?

9-Valent HPV Vaccine in Managing Squamous Cell Carcinoma: Case Report

Early-Onset Basal Cell Carcinoma and Cosmetic Tattoos

Role of Autophagy-Related Gene 7 in Non-Melanoma Skin Cancer

Identifying Squamous Cell Carcinoma With Gold Nanoparticle Technology

Quantitative Proteomics Analysis Yields Insights in Merkel Cell Carcinoma

Potential Biomarker of Response to Vismodegib in Basal Cell Carcinoma

Update on Laser Therapies for Basal Cell Carcinoma

Researchers Identify New RNA Molecule in Growth of Squamous Cell Carcinoma

Pilot Study to Investigate Same-Day Diagnosis and Treatment of Basal Cell Carcinomas

Characterizing Bioenergetics of Basal Cell and Squamous Cell Carcinomas

Use of Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma

Evaluating Risk of Basal Cell Carcinoma Linked to Solar Ultraviolet Exposure

Risk of Internal Malignancies in Patients With Non-Melanoma Skin Cancer

Potential Link Between Psoriasis and Risk of Non-Melanoma Skin Cancer

Detecting Skin Cancer Using a Neural Network Algorithm

Patient Preference for Prevention of Non-Melanoma Skin Cancer After Organ Transplantation

ASTRO Clinical Practice Guideline for Radiation Therapy for Basal Cell and Squamous Cell Skin Cancers

Pilot Study Explores Potential Therapeutic Target for Merkel Cell Carcinoma

Alternative Reconstruction Option for Cutaneous Malignancy

Voriconazole and Development of Squamous Cell Carcinoma: Potential Mechanism Identified

Potential Link Between Kidney Disease and Increased Risk for Cutaneous Squamous Cell Carcinoma

Indoor Tanning: Increased Risk for Cutaneous Squamous Cell Carcinoma?

Do Individuals With Psoriasis Have an Increased Risk of Keratinocyte Cancers?

Cancer-Testis Antigens: Immunotherapy Targets for Merkel Cell Carcinoma?

Pembrolizumab for Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma: A Case Study

Comparison of Cosmesis With Four Treatments for Basal and Squamous Cell Carcinomas

Treatment of Basal Cell Carcinoma With Topical Itraconazole

‘Man With Machine’ Approach to Diagnosing Skin Cancer Lesions

Risk of Non-Melanoma Skin Cancer in Patients With Rare Genodermatosis

Grading of Non-Melanoma Skin Cancers: Mohs Micrographic Surgery vs. Initial Biopsy

Long-Term Outcomes With Mohs Surgery for Cutaneous Squamous Cell Carcinoma

Pembrolizumab Therapy for Inoperable Case of Squamous Cell Carcinoma

Does a Family History of Melanoma Increase the Risk of Keratinocyte Cancers?

Risk Factors for Non-Melanoma Skin Cancers in Recipients of Kidney Transplant

Case Study: Rare Keratoacanthoma and Presence of HPV39

Patterns of Major Surgery for Cutaneous Squamous Cell Carcinoma

Use of Avelumab in Merkel Cell Carcinoma: Linking Early Response With Overall Survival

Meta-analysis of Treatment of Skin Cancers With PD-1/PD-L1 Inhibitors

Quality of Life With Vismodegib Treatment of Non-Melanoma Skin Cancers

Standardized Total Body Skin Exam: Improved Accuracy and Efficiency?

Physicians Versus Machine-Learning Algorithms in Classifying Pigmented Skin Lesions

Factors Affecting Survival for Patients with Advanced Cutaneous Squamous Cell Carcinoma

Does PD-1 Expression Differ by Histology in Cutaneous Squamous Cell Carcinoma?

Treatment Patterns for Canadian Patients With Head and Neck Squamous Cell Carcinoma

Multikinase Inhibitor Shows Activity in Aggressive Subtype of Squamous Cell Carcinoma

Predicting Response to Immunotherapy in Squamous Cell Carcinoma

Link Between Skin Cancer Diagnosis and Health-Care Screening Practices

Molecular Role of Complement C3a in Cutaneous Squamous Cell Cancer

Does Squamous Cell Carcinoma Risk Change With Immunosuppression?

Extremity Nevus Count and Risk of Skin Cancers

Association of Indoor Tanning and Skin Cancer in Canada

Is There an Association Between Skin Cancer and Erectile Dysfunction Medications?

Keratinocyte Carcinoma: Update on Treatment and Prevention

Intermittent Vismodegib Regimen for Locally Advanced Basal Cell Carcinoma

Use of Pembrolizumab in First-Line Treatment of Merkel Cell Carcinoma

Comparing Staging Systems in Cutaneous Squamous Cell Carcinoma

Impact of HLA Antigen Mismatches on Skin Cancer Risk in Transplant Recipients

Use of Cetuximab in Multimodality Treatment of Cutaneous Squamous Cell Carcinoma

Factors Contributing to Recurrence of Invasive Squamous Cell Carcinoma

How BMI Interacts With Sun Exposure and Risk of Non-Melanoma Skin Cancer

Using Immunohistochemical Panel to Differentiate Basal Cell Carcinoma and Trichoepithelioma

Risk Factors of Aggressive Skin Cancer in Recipients of Solid Organ Transplants

Research Points to Certain Genetic Links to Cutaneous Squamous Cell Carcinoma

Organ Transplantation and Degree of Differentiation of Cutaneous Squamous Cell Carcinoma

Risk of New Skin Neoplasms in Patients With History of Skin Cancer

Merkel Cell Carcinoma: Need for Timely Diagnosis and Treatment

Study Sheds Light on Cellular Origin of Merkel Cell Carcinoma

Are Some Transplant Recipients Exposed to Voriconazole at Risk for Skin Cancer?

Impact of Tumor Board Conferences on Treatment of Skin Cancer

Master Transcription Factors in Progression of Squamous Cell Carcinoma

Mohs Surgery for High-Risk Squamous Cell Carcinoma

Could Gentian Violet Be Used to Treat Cutaneous T-Cell Lymphoma?

Comparing Outcomes of Different Basal Cell Carcinoma Treatments

MAVORIC Results Support FDA Approval of Mogamulizumab in Cutaneous C-Cell Lymphoma

Case Study Highlights Novel Concurrent Therapy for Cutaneous Squamous Cell Carcinoma

Impact of Non‐Melanoma Skin Cancers on Patients’ Quality of Life

Update on Nonsurgical Treatments of Non-Melanoma Skin Cancer

Identifying Sentinel Lymph Nodes in Merkel Cell Cancer With Indocyanine Green

Do Frequent Occurrences of Basal Cell Carcinoma Increase Risk for Other Cancers?

Do UVA Nail Lamps Pose Cutaneous Carcinogenic Risk?

Identifying Renal Transplant Patients at Risk for Squamous Cell Carcinoma by DNA Methylation of T Cells

Depth of Follicular Involvement in Invasive Squamous Cell Carcinoma

Does Renal Transplant Rejection Influence Risk of Developing Squamous Cell Carcinoma?

Delayed Skin Reactions Reported With PD-1 Inhibitors

Comparison of Photodynamic Therapies for Active Keratosis

New Guidelines for Treating Metastatic Merkel Cell Carcinoma: Focus on Immunotherapy

Squamous Cell Carcinoma of the Lip: Is There a Difference Between Vermilion vs Cutaneous Involvement?

First-Line Avelumab for Metastatic Merkel Cell Carcinoma

Is There a Link Between Skin Cancers and Alzheimer’s Disease?

AAD Guidelines for Non-Melanoma Skin Cancers

Workplace UV Exposure = Quantifiable Economic Costs

Melanoma Mortality Risk and Nonmelanoma Cancer History: Is There a Connection?